InnoCan Pharma Corporation (INNO.CN)

0.2350 -0.0100 (-4.08%) At close: 01:25PM EDT

InnoCan Pharma Corporation

1015, 926 – 5 Avenue SW
Calgary, AB T2P 0N7
Canada
403 777 1519
https://innocanpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ron Mayron	Exec. Chairman	288k	N/A	1963
Ms. Iris Bincovich	CEO & Director	645k	N/A	1969
Mr. Yoram Drucker	Founder, Exec. VP of Bus. Devel. & Director	398k	N/A	1965
Mr. Nelson Harvey Halpern F.C.A., FCPA	Chief Financial Officer	111k	N/A	1959
Mr. Nir Avram B.Sc., M.Sc.	Chief Technology Officer	N/A	N/A	N/A
Mr. Eyal Flom L.L.M., M.B.A.	Director & Company Sec.	N/A	N/A	1966
Roni Kamhi	Chief Operating Officer	N/A	N/A	N/A
Mr. Moshe Hukaylo	Chief Financial Officer of InnoCan Pharma Ltd.	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.

Corporate Governance

InnoCan Pharma Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.